||Ain Shams University, Cairo, Egypt
||Harbor Hospital Center, Baltimore, Maryland
||Georgetown University Medical Center, Medical Oncology and Bone Marrow Transplantation
Roswell Park Cancer Institute, Medical Oncology
||National Boards of Internal Medicine and Medical Oncology
Selected from over 50 peer-reviewed journal articles:
Badros A, Barlogie B, Morris C, et. al. High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions. Blood 2001; 97: 2574-2579.
Badros A, Barlogie B, Siegel E, et.al. Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years. British Journal of Haematology. 2001:114:600-607.
Badros A, Barlogie B, Siegel E, et.al. Results of Autologous Stem Cell Transplant in Multiple Myeloma Patients with Renal Failure. British Journal of Haematology 2001; 114: 822-829.
Badros A, Tricot G, Toor A, et.al. ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning. Transfusion 2002; 42: 205-209.
Badros A, Barlogie B, Siegel E, et.al. Improved outcome of Non-myeloablative Allogeneic Transplantation in Multiple Myeloma. Journal of Clinical Oncology, 2002; 20: 1295-1303.
Badros AZ, Siegel E, Bodenner D, et.al. Hypothyroidism in patients with multiple myeloma following treatment with thalidomide. American Journal of Medicine. 2002; 112: 412-413.
Badros AZ, Goloubeva O, Rapoport AP, et.al. Phase II Study of G3139, a Bcl-2 Antisense Oligonucleotide, in Combination With Dexamethasone and Thalidomide in Relapsed Multiple Myeloma Patients. J Clin Oncol. 2005 Jun 20;23(18):4089-99. Epub 2005 May 2.
Badros A, Gahres N. Bortezomib, thalidomide, and dexamethasone for relapsed multiple myeloma: add it up and wait. Clin Adv Hematol Oncol. 2005 Dec;3(12):916-7; discussion 918.
Badros A, Weikel D, Salama A, et.al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol. 2006 Feb 20; 24(6):945-52.
Badros A, Jaccard A. Bevacizumab Therapy for POEMS Syndrome. Blood. 2006 Jun 15;107 (12):4972-4.
Breyer RJ 3rd, Mulligan ME, Smith SE, Line BR, Badros AZ. Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma. Skeletal Radiol. 2006 Jun 7 [Epub ahead of print]